Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

SHE:300289 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	915.94	566.02	574.27	565.02	798.81	928.6
Trading Asset Securities	-	336.75	316.14	290.29	-	-
Cash & Short-Term Investments	915.94	902.77	890.41	855.32	798.81	928.6
Cash Growth	2.86%	1.39%	4.10%	7.07%	-13.98%	163.41%
Accounts Receivable	85.16	92.32	99.02	149.76	184.48	232.4
Other Receivables	1.88	12.88	19.56	2.4	6.05	5.67
Receivables	87.05	105.2	118.58	152.16	190.52	238.08
Inventory	84.71	88.72	89.45	88.28	97.44	102.48
Other Current Assets	17.63	5.36	8.71	9.93	23.73	9.96
Total Current Assets	1,105	1,102	1,107	1,106	1,111	1,279
Property, Plant & Equipment	365.33	373.7	402.3	427.68	458.68	474.96
Long-Term Investments	1.13	10.72	11.17	23.66	20.9	1.01
Goodwill	73.53	73.53	73.53	144.66	159.54	190.07
Other Intangible Assets	19.02	20.98	25.17	28.74	33.89	37.74
Long-Term Accounts Receivable	-	7.42	1.17	-	-	-
Long-Term Deferred Tax Assets	40.76	41.07	46.93	43.06	35.52	27.95
Long-Term Deferred Charges	7.9	5.6	12.02	17.23	24.56	26.15
Other Long-Term Assets	142.93	141.1	142.99	147.69	156.22	311.41
Total Assets	1,756	1,776	1,822	1,938	2,000	2,348

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	18.07	20.72	19.79	32.87	18.47	36.32
Accrued Expenses	0.68	8.03	8.21	17.56	31.34	25.8
Current Portion of Long-Term Debt	2.66	-	-	-	-	-
Current Portion of Leases	-	3.04	4.11	4.29	3.73	3.31
Current Income Taxes Payable	3.15	1.56	1.04	2.17	2	2.08
Current Unearned Revenue	9.8	10.38	10.27	10.86	7.91	8.2
Other Current Liabilities	41	43	37.78	38.63	89.57	103.49
Total Current Liabilities	75.36	86.73	81.2	106.38	153.01	179.21
Long-Term Leases	0.04	1.16	0.72	4.65	8.12	9.82
Long-Term Unearned Revenue	13.89	14.09	14.57	15.5	18.32	19.07
Long-Term Deferred Tax Liabilities	2.11	2.81	6.67	6.45	6.71	3.01
Other Long-Term Liabilities	0.66	0.66	0.68	0.79	33.19	159.19
Total Liabilities	92.06	105.46	103.84	133.77	219.35	370.3

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	544.01	544.01	544.01	544.01	544.01	544.01
Additional Paid-In Capital	610.81	610.81	610.81	610.81	610.81	651.39
Retained Earnings	477.18	484.29	507.28	587.82	572.48	639.63
Total Common Equity	1,632	1,639	1,662	1,743	1,727	1,835
Minority Interest	31.86	31.62	56.48	61.99	53.16	143.08
Shareholders' Equity	1,664	1,671	1,719	1,805	1,780	1,978
Total Liabilities & Equity	1,756	1,776	1,822	1,938	2,000	2,348

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	2.7	4.2	4.83	8.95	11.84	13.13
Net Cash (Debt)	913.24	898.57	885.58	846.37	786.97	915.47
Net Cash Growth	3.22%	1.47%	4.63%	7.55%	-14.04%	192.03%
Net Cash Per Share	1.68	1.65	1.63	1.56	1.40	2.04
Filing Date Shares Outstanding	541.8	544.01	544.01	544.01	544.01	544.01
Total Common Shares Outstanding	541.8	544.01	544.01	544.01	544.01	544.01
Working Capital	1,030	1,015	1,026	999.3	957.49	1,100
Book Value Per Share	3.01	3.01	3.06	3.20	3.18	3.37
Tangible Book Value	1,539	1,545	1,563	1,569	1,534	1,607
Tangible Book Value Per Share	2.84	2.84	2.87	2.88	2.82	2.95
Buildings	-	479.36	486.27	495.09	488.24	487.72
Machinery	-	288.13	281.56	253.19	245.25	231.03
Construction In Progress	-	2.09	0.58	0.52	6.4	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error